(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IGFBP1 mRNA] CTD PMID:31150632 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 1,1-dichloroethene decreases expression ISO Igfbp1 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of IGFBP1 mRNA CTD PMID:26682919 1-methylphenanthrene multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of IGFBP1 mRNA CTD PMID:17690111 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of IGFBP1 mRNA CTD PMID:17522070 more ... 1-naphthyl isothiocyanate multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of IGFBP1 mRNA CTD PMID:27344345 1-naphthyl isothiocyanate increases expression ISO Igfbp1 (Mus musculus) 6480464 1-Naphthylisothiocyanate results in increased expression of IGFBP1 mRNA CTD PMID:15913567 17alpha-ethynylestradiol increases expression ISO Igfbp1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of IGFBP1 mRNA CTD PMID:14976129 17alpha-ethynylestradiol multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IGFBP1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of IGFBP1 mRNA CTD PMID:15795090 17beta-estradiol multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Cyclic AMP co-treated with Estradiol co-treated with Progesterone] results in increased expression of IGFBP1 mRNA more ... CTD PMID:11756571 more ... 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of IGFBP1 mRNA CTD PMID:32145629 17beta-estradiol decreases expression ISO IGFBP1 (Homo sapiens) 6480464 Estradiol results in decreased expression of IGFBP1 mRNA CTD PMID:31646340 17beta-estradiol increases expression ISO IGFBP1 (Homo sapiens) 6480464 Estradiol results in increased expression of IGFBP1 mRNA and Estradiol results in increased expression of IGFBP1 protein CTD PMID:12154049 more ... 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO IGFBP1 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of IGFBP1 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Igfbp1 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 2,2'-bipyridine increases expression ISO IGFBP1 (Homo sapiens) 6480464 2 and 2'-Dipyridyl results in increased expression of IGFBP1 mRNA CTD PMID:19924283 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Igfbp1 (Mus musculus) 6480464 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA] more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Igfbp1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP1 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO IGFBP1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA and Tetrachlorodibenzodioxin results in increased expression of IGFBP1 protein CTD PMID:15056799 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA] CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Igfbp1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP1 mRNA and Tetrachlorodibenzodioxin results in increased expression of IGFBP1 protein CTD PMID:16960034 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO IGFBP1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Igfbp1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP1 mRNA CTD PMID:17949056 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of IGFBP1 mRNA CTD PMID:21346803 2-amino-2-deoxy-D-galactopyranose increases expression EXP 6480464 Galactosamine results in increased expression of IGFBP1 mRNA CTD PMID:11779202 2-butoxyethanol increases expression ISO Igfbp1 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of IGFBP1 mRNA CTD PMID:19812364 2-hydroxy-17beta-estradiol increases expression ISO IGFBP1 (Homo sapiens) 6480464 2-hydroxyestradiol results in increased expression of IGFBP1 mRNA CTD PMID:32781018 2-hydroxy-17beta-estradiol multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 2-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:32781018 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of IGFBP1 mRNA CTD PMID:15890375 28-Homobrassinolide increases expression EXP 6480464 homobrassinolide results in increased expression of IGFBP1 mRNA CTD PMID:21491949 3',5'-cyclic AMP multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 2-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] more ... CTD PMID:31953017 more ... 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:19692669 and PMID:20959002 3,3',4,4',5-pentachlorobiphenyl affects expression ISO Igfbp1 (Mus musculus) 6480464 3 more ... CTD PMID:37080397 3-chloropropane-1,2-diol multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [alpha-Chlorohydrin co-treated with glycidol] results in increased expression of IGFBP1 mRNA CTD PMID:33187795 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of IGFBP1 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of IGFBP1 mRNA CTD PMID:18289764 and PMID:25380136 4,4'-sulfonyldiphenol decreases expression ISO Igfbp1 (Mus musculus) 6480464 bisphenol S results in decreased expression of IGFBP1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO IGFBP1 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of IGFBP1 gene CTD PMID:31601247 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of IGFBP1 mRNA CTD PMID:15890375 4-hydroxy-17beta-estradiol increases expression ISO IGFBP1 (Homo sapiens) 6480464 4-hydroxyestradiol results in increased expression of IGFBP1 mRNA CTD PMID:32781018 4-hydroxy-17beta-estradiol multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 4-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:32781018 4-hydroxyphenyl retinamide increases expression ISO Igfbp1 (Mus musculus) 6480464 Fenretinide results in increased expression of IGFBP1 mRNA CTD PMID:28973697 5-azacytidine multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA] and Azacitidine promotes the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 protein] CTD PMID:20823114 5-azacytidine increases expression ISO IGFBP1 (Homo sapiens) 6480464 Azacitidine results in increased expression of IGFBP1 mRNA CTD PMID:20823114 8-Br-cAMP increases secretion ISO IGFBP1 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased secretion of IGFBP1 protein CTD PMID:21273127 8-Br-cAMP increases expression ISO IGFBP1 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA and 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 protein CTD PMID:17065600 more ... 8-Br-cAMP decreases expression ISO IGFBP1 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IGFBP1 mRNA and 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IGFBP1 protein CTD PMID:18815356 8-Br-cAMP multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 1-Butanol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA] more ... CTD PMID:16709600 more ... afimoxifene increases expression ISO IGFBP1 (Homo sapiens) 6480464 afimoxifene results in increased expression of IGFBP1 mRNA CTD PMID:12154049 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of IGFBP1 mRNA CTD PMID:15890375 and PMID:25378103 aflatoxin B1 decreases methylation ISO IGFBP1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of IGFBP1 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO IGFBP1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of IGFBP1 mRNA CTD PMID:21632981 more ... aflatoxin B1 affects expression ISO IGFBP1 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of IGFBP1 protein CTD PMID:20106945 amiodarone increases expression ISO IGFBP1 (Homo sapiens) 6480464 Amiodarone results in increased expression of IGFBP1 mRNA CTD PMID:27089845 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IGFBP1 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of IGFBP1 mRNA CTD PMID:15183010 Archazolid B increases expression ISO IGFBP1 (Homo sapiens) 6480464 archazolid B results in increased expression of IGFBP1 mRNA CTD PMID:25218289 aristolochic acids increases expression EXP 6480464 Aristolochic Acids results in increased expression of IGFBP1 mRNA CTD PMID:19717638 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of IGFBP1 mRNA CTD PMID:18178546 arsenite(3-) multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [arsenite results in decreased expression of IGFBP1 mRNA] CTD PMID:31646340 arsenite(3-) decreases expression ISO IGFBP1 (Homo sapiens) 6480464 arsenite results in decreased expression of IGFBP1 mRNA CTD PMID:31646340 arsenous acid multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of IGFBP1 protein CTD PMID:27430728 arsenous acid increases expression ISO Igfbp1 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of IGFBP1 mRNA CTD PMID:15073043 atazanavir sulfate multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of IGFBP1 mRNA CTD PMID:33819548 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA CTD PMID:33854195 bacitracin increases expression EXP 6480464 Bacitracin results in increased expression of IGFBP1 mRNA CTD PMID:18289764 benzo[a]pyrene decreases expression ISO Igfbp1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of IGFBP1 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO IGFBP1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of IGFBP1 exon and Benzo(a)pyrene results in increased methylation of IGFBP1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO IGFBP1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of IGFBP1 mRNA and Benzo(a)pyrene results in increased expression of IGFBP1 protein CTD PMID:16269432 more ... benzo[a]pyrene multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 benzo[a]pyrene diol epoxide I increases expression ISO IGFBP1 (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 benzo[b]fluoranthene multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of IGFBP1 mRNA CTD PMID:17690111 benzo[b]fluoranthene increases expression ISO IGFBP1 (Homo sapiens) 6480464 benzo(b)fluoranthene results in increased expression of IGFBP1 mRNA CTD PMID:16269432 beta-naphthoflavone increases expression ISO IGFBP1 (Homo sapiens) 6480464 beta-Naphthoflavone results in increased expression of IGFBP1 mRNA CTD PMID:19737606 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of IGFBP1 mRNA CTD PMID:16648578 bicalutamide multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP1 protein CTD PMID:16847815 bis(2-ethylhexyl) phthalate increases expression ISO Igfbp1 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of IGFBP1 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO Igfbp1 (Mus musculus) 6480464 PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IGFBP1 mRNA] CTD PMID:19850644 bisphenol A increases expression ISO IGFBP1 (Homo sapiens) 6480464 bisphenol A results in increased expression of IGFBP1 mRNA and bisphenol A results in increased expression of IGFBP1 protein CTD PMID:21273127 more ... bisphenol A increases expression ISO Igfbp1 (Mus musculus) 6480464 bisphenol A results in increased expression of IGFBP1 mRNA CTD PMID:30245210 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of IGFBP1 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO Igfbp1 (Mus musculus) 6480464 bisphenol A results in decreased expression of IGFBP1 mRNA CTD PMID:30951980 bisphenol A affects expression ISO IGFBP1 (Homo sapiens) 6480464 bisphenol A affects the expression of IGFBP1 mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of IGFBP1 mRNA CTD PMID:30816183 more ... bisphenol A multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Progesterone co-treated with bisphenol A] results in increased expression of IGFBP1 mRNA CTD PMID:26604029 bisphenol A increases secretion ISO IGFBP1 (Homo sapiens) 6480464 bisphenol A results in increased secretion of IGFBP1 protein CTD PMID:26604029 bisphenol F decreases expression ISO Igfbp1 (Mus musculus) 6480464 bisphenol F results in decreased expression of IGFBP1 mRNA CTD PMID:30951980 bucladesine increases expression ISO IGFBP1 (Homo sapiens) 6480464 Bucladesine results in increased expression of IGFBP1 CTD PMID:12093828 bucladesine multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA more ... CTD PMID:20823114 and PMID:30328349 butan-1-ol multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 1-Butanol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA] CTD PMID:17065600 butanal decreases expression ISO IGFBP1 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of IGFBP1 mRNA CTD PMID:26079696 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of IGFBP1 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [Cadmium results in decreased expression of IGFBP1 mRNA] CTD PMID:31646340 cadmium atom decreases expression ISO IGFBP1 (Homo sapiens) 6480464 Cadmium results in decreased expression of IGFBP1 mRNA CTD PMID:31646340 cadmium dichloride increases expression ISO IGFBP1 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of IGFBP1 protein CTD PMID:26138014 cadmium dichloride multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IGFBP1 protein] CTD PMID:26138014 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of IGFBP1 mRNA CTD PMID:25993096 caffeine increases expression ISO IGFBP1 (Homo sapiens) 6480464 Caffeine results in increased expression of IGFBP1 mRNA CTD PMID:11793227 calcitriol increases expression ISO IGFBP1 (Homo sapiens) 6480464 Calcitriol results in increased expression of IGFBP1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of IGFBP1 mRNA CTD PMID:21592394 cannabidiol multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 Cannabidiol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:31953017 carbamazepine affects expression ISO IGFBP1 (Homo sapiens) 6480464 Carbamazepine affects the expression of IGFBP1 mRNA CTD PMID:24752500 chenodeoxycholic acid decreases expression ISO Igfbp1 (Mus musculus) 6480464 Chenodeoxycholic Acid results in decreased expression of IGFBP1 mRNA CTD PMID:19072826 chenodeoxycholic acid multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of IGFBP1 mRNA more ... CTD PMID:33819548 chlorpromazine increases expression ISO IGFBP1 (Homo sapiens) 6480464 Chlorpromazine results in increased expression of IGFBP1 mRNA CTD PMID:15924885 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA CTD PMID:33854195 cholesterol multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [Cholesterol co-treated with 1 and 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of IGFBP1 mRNA CTD PMID:22129739 choline multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGFBP1 mRNA CTD PMID:20938992 chromium(3+) trichloride decreases expression ISO Igfbp1 (Mus musculus) 6480464 chromic chloride results in decreased expression of IGFBP1 mRNA CTD PMID:12153762 ciguatoxin CTX1B affects expression ISO Igfbp1 (Mus musculus) 6480464 Ciguatoxins affects the expression of IGFBP1 mRNA CTD PMID:18353800 ciprofibrate increases expression ISO Igfbp1 (Mus musculus) 6480464 ciprofibrate results in increased expression of IGFBP1 mRNA CTD PMID:12771043 cisplatin affects expression EXP 6480464 Cisplatin affects the expression of IGFBP1 mRNA CTD PMID:18289764 cisplatin multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of IGFBP1 mRNA CTD PMID:27392435 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of IGFBP1 mRNA CTD PMID:17522070 clofibrate decreases expression ISO Igfbp1 (Mus musculus) 6480464 Clofibrate results in decreased expression of IGFBP1 mRNA CTD PMID:17585979 and PMID:23811191 clofibrate multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of IGFBP1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBP1 mRNA] CTD PMID:17585979 clofibrate increases expression ISO Igfbp1 (Mus musculus) 6480464 Clofibrate results in increased expression of IGFBP1 mRNA CTD PMID:11356909 clotrimazole increases expression ISO IGFBP1 (Homo sapiens) 6480464 Clotrimazole results in increased expression of IGFBP1 mRNA CTD PMID:12659874 clotrimazole increases secretion ISO IGFBP1 (Homo sapiens) 6480464 Clotrimazole results in increased secretion of IGFBP1 protein CTD PMID:12659874 clozapine increases expression ISO IGFBP1 (Homo sapiens) 6480464 Clozapine results in increased expression of IGFBP1 protein CTD PMID:36482696 cobalt dichloride increases expression ISO Igfbp1 (Mus musculus) 6480464 cobaltous chloride results in increased expression of IGFBP1 mRNA and cobaltous chloride results in increased expression of IGFBP1 protein CTD PMID:16990490 cobalt dichloride decreases expression ISO Igfbp1 (Mus musculus) 6480464 cobaltous chloride results in decreased expression of IGFBP1 mRNA CTD PMID:21139344 colforsin daropate hydrochloride increases expression ISO IGFBP1 (Homo sapiens) 6480464 Colforsin results in increased expression of IGFBP1 CTD PMID:12093828 colforsin daropate hydrochloride multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of IGFBP1 mRNA CTD PMID:31154070 copper(II) sulfate increases expression ISO IGFBP1 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of IGFBP1 mRNA CTD PMID:19549813 corn oil affects expression EXP 6480464 Corn Oil affects the expression of IGFBP1 mRNA CTD PMID:16360708 cortisol multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 Hydrocortisone promotes the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]] CTD PMID:23275455 curcumin multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Curcumin] results in decreased expression of IGFBP1 protein CTD PMID:27430728 cyanamide multiple interactions EXP 6480464 Cyanamide inhibits the reaction [Ethanol results in increased expression of IGFBP1 mRNA] CTD PMID:12394292 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of IGFBP1 mRNA CTD PMID:21865292 cyclosporin A multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of IGFBP1 mRNA CTD PMID:33819548 cyclosporin A increases expression ISO IGFBP1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of IGFBP1 mRNA CTD PMID:20106945 more ... cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of IGFBP1 mRNA CTD PMID:21865292 cypermethrin decreases expression ISO Igfbp1 (Mus musculus) 6480464 cypermethrin results in decreased expression of IGFBP1 mRNA and cypermethrin results in decreased expression of IGFBP1 protein CTD PMID:36116546 deoxycholic acid decreases expression ISO IGFBP1 (Homo sapiens) 6480464 Deoxycholic Acid results in decreased expression of IGFBP1 mRNA CTD PMID:27089845 deoxycholic acid multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of IGFBP1 mRNA more ... CTD PMID:33819548 dexamethasone multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Dexamethasone results in increased phosphorylation of and results in increased activity of NR3C1 protein] which results in increased expression of IGFBP1 mRNA and Dexamethasone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA] CTD PMID:18483179 and PMID:23275455 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of IGFBP1 mRNA CTD PMID:17522070 diarsenic trioxide increases expression ISO Igfbp1 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of IGFBP1 mRNA CTD PMID:15073043 diarsenic trioxide multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of IGFBP1 protein CTD PMID:27430728 dibenz[a,h]anthracene increases expression ISO IGFBP1 (Homo sapiens) 6480464 1 more ... CTD PMID:16269432 dibenz[a,h]anthracene decreases expression ISO Igfbp1 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 dibenz[a,h]anthracene multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 dibenzo[a,l]pyrene increases expression ISO IGFBP1 (Homo sapiens) 6480464 dibenzo(a and l)pyrene results in increased expression of IGFBP1 mRNA CTD PMID:16269432 dibenzo[a,l]pyrene multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with dibenzo(a and l)pyrene] affects the expression of IGFBP1 mRNA CTD PMID:17690111 dichloroacetic acid increases expression ISO Igfbp1 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of IGFBP1 mRNA CTD PMID:28962523 diclofenac affects expression ISO IGFBP1 (Homo sapiens) 6480464 Diclofenac affects the expression of IGFBP1 mRNA CTD PMID:24752500 diclofenac increases expression ISO Igfbp1 (Mus musculus) 6480464 Diclofenac results in increased expression of IGFBP1 mRNA CTD PMID:26934552 diethylstilbestrol multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of IGFBP1 mRNA CTD PMID:19665456 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of IGFBP1 mRNA CTD PMID:15890375 dimethylarsinic acid increases expression ISO Igfbp1 (Mus musculus) 6480464 Cacodylic Acid results in increased expression of IGFBP1 mRNA CTD PMID:15345372 dioxygen increases expression ISO IGFBP1 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of IGFBP1 mRNA CTD PMID:19924283 doxorubicin increases expression ISO Igfbp1 (Mus musculus) 6480464 Doxorubicin results in increased expression of IGFBP1 protein CTD PMID:30517846 doxorubicin increases expression ISO IGFBP1 (Homo sapiens) 6480464 Doxorubicin results in increased expression of IGFBP1 mRNA CTD PMID:29803840 enalapril increases expression EXP 6480464 Enalapril results in increased expression of IGFBP1 mRNA CTD PMID:12883983 epoxiconazole increases expression ISO Igfbp1 (Mus musculus) 6480464 epoxiconazole results in increased expression of IGFBP1 mRNA CTD PMID:35436446 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of IGFBP1 mRNA CTD PMID:17522070 ethanol decreases expression ISO Igfbp1 (Mus musculus) 6480464 Ethanol results in decreased expression of IGFBP1 mRNA CTD PMID:19167417 ethanol increases expression EXP 6480464 Ethanol results in increased expression of IGFBP1 mRNA CTD PMID:12394292 ethanol multiple interactions EXP 6480464 Cyanamide inhibits the reaction [Ethanol results in increased expression of IGFBP1 mRNA] CTD PMID:12394292 fentin chloride increases expression EXP 6480464 triphenyltin chloride results in increased expression of IGFBP1 mRNA CTD PMID:37156404 folic acid multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGFBP1 mRNA CTD PMID:20938992 fulvestrant increases expression ISO IGFBP1 (Homo sapiens) 6480464 Fulvestrant results in increased expression of IGFBP1 mRNA CTD PMID:31646340 fulvestrant multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [arsenite results in decreased expression of IGFBP1 mRNA] more ... CTD PMID:31646340 fumonisin B1 increases expression ISO Igfbp1 (Mus musculus) 6480464 fumonisin B1 results in increased expression of IGFBP1 mRNA CTD PMID:16221962 furan increases expression ISO Igfbp1 (Mus musculus) 6480464 furan results in increased expression of IGFBP1 mRNA CTD PMID:24183702 and PMID:37517673 furan decreases expression EXP 6480464 furan results in decreased expression of IGFBP1 mRNA CTD PMID:26194646 genistein decreases expression EXP 6480464 Genistein results in decreased expression of IGFBP1 mRNA CTD PMID:17049845 genistein increases expression EXP 6480464 Genistein results in increased expression of IGFBP1 mRNA CTD PMID:15795090 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of IGFBP1 mRNA CTD PMID:18289764 glycidol multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [alpha-Chlorohydrin co-treated with glycidol] results in increased expression of IGFBP1 mRNA CTD PMID:33187795 glycochenodeoxycholic acid multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of IGFBP1 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of IGFBP1 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of IGFBP1 mRNA more ... CTD PMID:33819548 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA CTD PMID:33854195 GW 4064 increases expression ISO Igfbp1 (Mus musculus) 6480464 GW 4064 results in increased expression of IGFBP1 mRNA CTD PMID:26655953 hydrogen peroxide multiple interactions EXP 6480464 Hydrogen Peroxide inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] CTD PMID:17213664 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA CTD PMID:33854195 indirubin increases expression ISO IGFBP1 (Homo sapiens) 6480464 indirubin results in increased expression of IGFBP1 mRNA CTD PMID:15056799 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA and Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA] CTD PMID:22129741 inulin multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGFBP1 mRNA CTD PMID:36331819 ketamine increases expression EXP 6480464 Ketamine results in increased expression of IGFBP1 mRNA CTD PMID:20080153 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of IGFBP1 mRNA CTD PMID:18289764 kynurenine increases expression ISO IGFBP1 (Homo sapiens) 6480464 Kynurenine results in increased expression of IGFBP1 mRNA CTD PMID:32781018 kynurenine multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Kynurenine promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]] and Kynurenine promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:32781018 L-methionine multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGFBP1 mRNA CTD PMID:20938992 L-tryptophan increases expression ISO IGFBP1 (Homo sapiens) 6480464 Tryptophan results in increased expression of IGFBP1 mRNA CTD PMID:32781018 L-tryptophan multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]] more ... CTD PMID:32781018 lead diacetate decreases expression ISO Igfbp1 (Mus musculus) 6480464 lead acetate results in decreased expression of IGFBP1 mRNA CTD PMID:25270620 lead diacetate increases expression ISO Igfbp1 (Mus musculus) 6480464 lead acetate results in increased expression of IGFBP1 mRNA CTD PMID:21335049 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of IGFBP1 mRNA CTD PMID:24136188 leflunomide increases expression ISO IGFBP1 (Homo sapiens) 6480464 leflunomide results in increased expression of IGFBP1 mRNA CTD PMID:28988120 lipopolysaccharide decreases expression ISO Igfbp1 (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of IGFBP1 mRNA CTD PMID:27339419 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of IGFBP1 mRNA CTD PMID:11779202 lisinopril dihydrate increases expression ISO IGFBP1 (Homo sapiens) 6480464 Lisinopril results in increased expression of IGFBP1 protein CTD PMID:9663927 medroxyprogesterone acetate multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 2-hydroxyestradiol promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] more ... CTD PMID:11756571 more ... medroxyprogesterone acetate increases expression ISO IGFBP1 (Homo sapiens) 6480464 Medroxyprogesterone Acetate results in increased expression of IGFBP1 mRNA CTD PMID:11756571 and PMID:20685861 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of IGFBP1 mRNA CTD PMID:7540432 metformin decreases expression ISO IGFBP1 (Homo sapiens) 6480464 Metformin results in decreased expression of IGFBP1 mRNA CTD PMID:21316309 metformin decreases expression EXP 6480464 Metformin results in decreased expression of IGFBP1 mRNA CTD PMID:31324951 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of IGFBP1 mRNA CTD PMID:15120968 and PMID:15890375 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of IGFBP1 mRNA CTD PMID:30467583 methylarsonic acid increases expression ISO Igfbp1 (Mus musculus) 6480464 monomethylarsonic acid results in increased expression of IGFBP1 mRNA CTD PMID:15345372 methylmercury(1+) decreases expression EXP 6480464 methylmercury II results in decreased expression of IGFBP1 mRNA CTD PMID:17905399 metyrapone multiple interactions EXP 6480464 [[Air Pollutants results in increased abundance of Ozone] which co-treated with Metyrapone] results in increased expression of IGFBP1 mRNA CTD PMID:37088303 microcystin-LR increases expression ISO Igfbp1 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of IGFBP1 mRNA CTD PMID:17654400 mifepristone multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 Mifepristone inhibits the reaction [Progesterone results in increased secretion of IGFBP1 protein] CTD PMID:26604029 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA] CTD PMID:22129741 N-acetyl-L-cysteine multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IGFBP1 protein] CTD PMID:26138014 N-nitrosodiethylamine increases expression ISO IGFBP1 (Homo sapiens) 6480464 Diethylnitrosamine results in increased expression of IGFBP1 mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA and Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA] CTD PMID:22129741 N-nitrosodiethylamine increases expression ISO Igfbp1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of IGFBP1 mRNA CTD PMID:12771043 more ... N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of IGFBP1 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of IGFBP1 mRNA and MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of IGFBP1 mRNA] CTD PMID:17942915 and PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of IGFBP1 mRNA CTD PMID:15890375 and PMID:25380136 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of IGFBP1 mRNA CTD PMID:17072980 N-Nitrosopyrrolidine increases expression ISO IGFBP1 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in increased expression of IGFBP1 mRNA CTD PMID:32234424 NAD zwitterion increases expression ISO IGFBP1 (Homo sapiens) 6480464 NAD results in increased expression of IGFBP1 mRNA CTD PMID:32781018 NAD zwitterion multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 NAD inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:32781018 NAD(+) multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 NAD inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] CTD PMID:32781018 NAD(+) increases expression ISO IGFBP1 (Homo sapiens) 6480464 NAD results in increased expression of IGFBP1 mRNA CTD PMID:32781018 nefazodone multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of IGFBP1 mRNA CTD PMID:33819548 nickel dichloride increases expression ISO IGFBP1 (Homo sapiens) 6480464 nickel chloride results in increased expression of IGFBP1 mRNA CTD PMID:21455298 nicotinamide multiple interactions ISO Igfbp1 (Mus musculus) 6480464 Niacinamide inhibits the reaction [FOXO1 protein results in increased expression of IGFBP1 mRNA] CTD PMID:16917544 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of IGFBP1 mRNA CTD PMID:27592368 and PMID:33484710 ochratoxin A decreases expression ISO IGFBP1 (Homo sapiens) 6480464 ochratoxin A results in decreased expression of IGFBP1 mRNA and ochratoxin A results in decreased expression of IGFBP1 protein CTD PMID:19287073 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of IGFBP1 mRNA CTD PMID:19717638 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of IGFBP1 mRNA CTD PMID:23665939 oxazepam increases expression ISO Igfbp1 (Mus musculus) 6480464 Oxazepam results in increased expression of IGFBP1 mRNA and Oxazepam results in increased expression of IGFBP1 protein CTD PMID:12727805 and PMID:15618236 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of IGFBP1 mRNA CTD PMID:23439660 ozone decreases expression ISO Igfbp1 (Mus musculus) 6480464 Ozone results in decreased expression of IGFBP1 mRNA CTD PMID:16183385 ozone multiple interactions EXP 6480464 [[Air Pollutants results in increased abundance of Ozone] which co-treated with Metyrapone] results in increased expression of IGFBP1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of IGFBP1 mRNA CTD PMID:37088303 paracetamol increases expression ISO Igfbp1 (Mus musculus) 6480464 Acetaminophen results in increased expression of IGFBP1 mRNA CTD PMID:17585979 paracetamol multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of IGFBP1 mRNA CTD PMID:33819548 paracetamol affects expression ISO Igfbp1 (Mus musculus) 6480464 Acetaminophen affects the expression of IGFBP1 mRNA CTD PMID:15606129 and PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of IGFBP1 mRNA CTD PMID:15120968 more ... paracetamol increases expression ISO IGFBP1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of IGFBP1 mRNA CTD PMID:11793227 and PMID:29067470 paracetamol multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of IGFBP1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBP1 mRNA] CTD PMID:17585979 paraquat multiple interactions EXP 6480464 Paraquat inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] CTD PMID:17213664 perfluorohexanesulfonic acid increases expression ISO Igfbp1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of IGFBP1 mRNA CTD PMID:37995155 perfluorononanoic acid increases expression ISO IGFBP1 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of IGFBP1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO IGFBP1 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of IGFBP1 mRNA CTD PMID:33772556 perfluorooctane-1-sulfonic acid affects expression ISO IGFBP1 (Homo sapiens) 6480464 perfluorooctane sulfonic acid affects the expression of IGFBP1 mRNA CTD PMID:36864359 perfluorooctane-1-sulfonic acid multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGFBP1 mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO IGFBP1 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of IGFBP1 protein CTD PMID:26879310 perfluorooctanoic acid increases expression ISO IGFBP1 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of IGFBP1 mRNA CTD PMID:33772556 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of IGFBP1 mRNA CTD PMID:28511854 phenobarbital multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of IGFBP1 mRNA and NR1I3 protein affects the reaction [Phenobarbital results in increased expression of IGFBP1 mRNA] CTD PMID:19482888 and PMID:24535843 phenobarbital affects expression ISO IGFBP1 (Homo sapiens) 6480464 Phenobarbital affects the expression of IGFBP1 mRNA CTD PMID:19084549 and PMID:19159669 phenobarbital increases secretion ISO IGFBP1 (Homo sapiens) 6480464 Phenobarbital results in increased secretion of IGFBP1 protein CTD PMID:12659874 phenobarbital increases expression ISO IGFBP1 (Homo sapiens) 6480464 Phenobarbital results in increased expression of IGFBP1 mRNA CTD PMID:12659874 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of IGFBP1 mRNA CTD PMID:19162173 phenobarbital increases expression ISO Igfbp1 (Mus musculus) 6480464 Phenobarbital results in increased expression of IGFBP1 mRNA CTD PMID:19482888 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in decreased expression of IGFBP1 mRNA CTD PMID:15059925 phorbol 13-acetate 12-myristate multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IGFBP1 mRNA CTD PMID:16368122 phorone affects expression EXP 6480464 phorone affects the expression of IGFBP1 mRNA CTD PMID:18198479 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of IGFBP1 mRNA CTD PMID:15890375 pirinixic acid multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of IGFBP1 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO Igfbp1 (Mus musculus) 6480464 pirinixic acid results in increased expression of IGFBP1 mRNA and pirinixic acid results in increased expression of IGFBP1 protein CTD PMID:12727805 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of IGFBP1 mRNA CTD PMID:15890375 potassium bromate increases expression EXP 6480464 potassium bromate results in increased expression of IGFBP1 mRNA CTD PMID:23588252 potassium dichromate decreases expression ISO Igfbp1 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of IGFBP1 mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of IGFBP1 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile increases expression ISO Igfbp1 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of IGFBP1 mRNA CTD PMID:28903501 pregnenolone 16alpha-carbonitrile decreases expression ISO Igfbp1 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of IGFBP1 mRNA CTD PMID:22698814 and PMID:27413110 progesterone affects expression ISO IGFBP1 (Homo sapiens) 6480464 Progesterone affects the expression of IGFBP1 mRNA and Progesterone affects the expression of IGFBP1 protein CTD PMID:15501902 progesterone increases expression ISO IGFBP1 (Homo sapiens) 6480464 Progesterone results in increased expression of IGFBP1 mRNA CTD PMID:17404688 more ... progesterone increases secretion ISO IGFBP1 (Homo sapiens) 6480464 Progesterone results in increased secretion of IGFBP1 protein CTD PMID:26604029 progesterone multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide inhibits the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]] more ... CTD PMID:17404688 more ... propanal decreases expression ISO IGFBP1 (Homo sapiens) 6480464 propionaldehyde results in decreased expression of IGFBP1 mRNA CTD PMID:26079696 quercetin decreases expression ISO IGFBP1 (Homo sapiens) 6480464 Quercetin results in decreased expression of IGFBP1 mRNA CTD PMID:21632981 quinolin-8-ol increases expression ISO IGFBP1 (Homo sapiens) 6480464 Oxyquinoline results in increased expression of IGFBP1 mRNA CTD PMID:21632981 resveratrol multiple interactions EXP 6480464 FOXO1 protein affects the reaction [resveratrol results in increased expression of IGFBP1 mRNA] and resveratrol inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] CTD PMID:15788402 and PMID:16626303 resveratrol multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of IGFBP1 mRNA CTD PMID:23557933 resveratrol increases expression ISO IGFBP1 (Homo sapiens) 6480464 resveratrol results in increased expression of IGFBP1 mRNA CTD PMID:12154049 resveratrol multiple interactions ISO Igfbp1 (Mus musculus) 6480464 resveratrol promotes the reaction [FOXO1 protein results in increased expression of IGFBP1 mRNA] CTD PMID:16917544 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of IGFBP1 mRNA CTD PMID:16236254 riddelliine increases expression EXP 6480464 riddelliine results in increased expression of IGFBP1 mRNA CTD PMID:18047727 rifampicin multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of IGFBP1 mRNA CTD PMID:21127053 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 Buthionine Sulfoximine inhibits the reaction [INS1 protein results in decreased expression of IGFBP1 mRNA] CTD PMID:17213664 silicon dioxide increases expression ISO IGFBP1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of IGFBP1 mRNA CTD PMID:25895662 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of IGFBP1 mRNA CTD PMID:21865292 sodium arsenite multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of IGFBP1 mRNA and [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IGFBP1 mRNA CTD PMID:16368122 and PMID:19665456 sodium arsenite decreases expression ISO Igfbp1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of IGFBP1 mRNA CTD PMID:17350061 and PMID:17451858 sodium arsenite increases expression ISO Igfbp1 (Mus musculus) 6480464 sodium arsenite results in increased expression of IGFBP1 mRNA CTD PMID:14691202 more ... sodium arsenite affects expression ISO Igfbp1 (Mus musculus) 6480464 sodium arsenite affects the expression of IGFBP1 mRNA CTD PMID:16507464 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of IGFBP1 mRNA CTD PMID:25993096 sotorasib multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IGFBP1 mRNA CTD PMID:36139627 starch multiple interactions EXP 6480464 Starch analog inhibits the reaction [Rapeseed Oil metabolite results in decreased expression of IGFBP1 mRNA] CTD PMID:27363782 stavudine increases expression EXP 6480464 Stavudine results in increased expression of IGFBP1 mRNA CTD PMID:18299183 succimer multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP1 mRNA CTD PMID:26378955 Sunset Yellow FCF multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of IGFBP1 mRNA CTD PMID:33819548 tacrolimus hydrate decreases expression EXP 6480464 Tacrolimus results in decreased expression of IGFBP1 mRNA CTD PMID:21865292 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of IGFBP1 mRNA CTD PMID:21865292 tamoxifen multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP1 protein CTD PMID:16847815 tamoxifen increases expression ISO IGFBP1 (Homo sapiens) 6480464 Tamoxifen results in increased expression of IGFBP1 mRNA CTD PMID:27089845 tamoxifen affects expression ISO Igfbp1 (Mus musculus) 6480464 Tamoxifen affects the expression of IGFBP1 mRNA CTD PMID:20937368 tauroursodeoxycholic acid increases expression EXP 6480464 ursodoxicoltaurine results in increased expression of IGFBP1 mRNA CTD PMID:15885361 testosterone multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of IGFBP1 mRNA CTD PMID:21592394 testosterone decreases expression ISO IGFBP1 (Homo sapiens) 6480464 Testosterone results in decreased expression of IGFBP1 mRNA CTD PMID:21592394 tetrachloroethene increases expression ISO Igfbp1 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of IGFBP1 mRNA CTD PMID:28973375 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of IGFBP1 mRNA CTD PMID:15963342 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IGFBP1 mRNA] CTD PMID:31150632 tetrachloromethane increases expression ISO Igfbp1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of IGFBP1 mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of IGFBP1 mRNA CTD PMID:15070850 more ... tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of IGFBP1 mRNA CTD PMID:17522070 tetracycline increases expression ISO IGFBP1 (Homo sapiens) 6480464 Tetracycline results in increased expression of IGFBP1 mRNA CTD PMID:27089845 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA CTD PMID:33854195 thioacetamide increases expression ISO IGFBP1 (Homo sapiens) 6480464 Thioacetamide results in increased expression of IGFBP1 mRNA CTD PMID:11793227 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of IGFBP1 mRNA CTD PMID:16297948 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of IGFBP1 mRNA CTD PMID:14739098 thioacetamide multiple interactions EXP 6480464 halofuginone inhibits the reaction [Thioacetamide results in decreased expression of IGFBP1 mRNA] CTD PMID:14739098 tianeptine increases expression ISO IGFBP1 (Homo sapiens) 6480464 tianeptine results in increased expression of IGFBP1 mRNA CTD PMID:27089845 titanium dioxide increases expression ISO Igfbp1 (Mus musculus) 6480464 titanium dioxide results in increased expression of IGFBP1 mRNA CTD PMID:23557971 tolcapone increases expression EXP 6480464 tolcapone results in increased expression of IGFBP1 mRNA CTD PMID:24136188 trametinib multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IGFBP1 mRNA CTD PMID:36139627 tributylstannane decreases expression ISO Igfbp1 (Mus musculus) 6480464 tributyltin results in decreased expression of IGFBP1 mRNA CTD PMID:31939706 trichloroethene increases expression ISO Igfbp1 (Mus musculus) 6480464 Trichloroethylene results in increased expression of IGFBP1 mRNA CTD PMID:25549359 triclosan increases expression ISO IGFBP1 (Homo sapiens) 6480464 Triclosan results in increased expression of IGFBP1 mRNA CTD PMID:26604029 and PMID:34681664 triclosan increases secretion ISO IGFBP1 (Homo sapiens) 6480464 Triclosan results in increased secretion of IGFBP1 protein CTD PMID:26604029 triclosan multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [Progesterone co-treated with Triclosan] results in increased expression of IGFBP1 mRNA and Progesterone promotes the reaction [Triclosan results in increased secretion of IGFBP1 protein] CTD PMID:26604029 Triptolide decreases expression ISO Igfbp1 (Mus musculus) 6480464 triptolide results in decreased expression of IGFBP1 mRNA CTD PMID:32835833 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of IGFBP1 mRNA CTD PMID:23639586 tris(2-butoxyethyl) phosphate affects expression ISO IGFBP1 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of IGFBP1 mRNA CTD PMID:29024780 troglitazone increases expression ISO IGFBP1 (Homo sapiens) 6480464 troglitazone results in increased expression of IGFBP1 mRNA CTD PMID:12659874 troglitazone decreases expression ISO IGFBP1 (Homo sapiens) 6480464 troglitazone results in decreased expression of IGFBP1 mRNA CTD PMID:25572481 troglitazone increases secretion ISO IGFBP1 (Homo sapiens) 6480464 troglitazone results in increased secretion of IGFBP1 protein CTD PMID:12659874 trovafloxacin multiple interactions ISO Igfbp1 (Mus musculus) 6480464 [trovafloxacin co-treated with lipopolysaccharide and E coli O55-B5] results in increased expression of IGFBP1 mRNA CTD PMID:18930950 tunicamycin increases expression ISO IGFBP1 (Homo sapiens) 6480464 Tunicamycin results in increased expression of IGFBP1 mRNA CTD PMID:33545341 urethane increases expression ISO IGFBP1 (Homo sapiens) 6480464 Urethane results in increased expression of IGFBP1 mRNA CTD PMID:28818685 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of IGFBP1 mRNA CTD PMID:15885361 valproic acid affects expression ISO Igfbp1 (Mus musculus) 6480464 Valproic Acid affects the expression of IGFBP1 mRNA CTD PMID:17963808 vancomycin affects expression EXP 6480464 Vancomycin affects the expression of IGFBP1 mRNA CTD PMID:18289764 vancomycin increases expression ISO Igfbp1 (Mus musculus) 6480464 Vancomycin results in increased expression of IGFBP1 mRNA CTD PMID:18930951 vandetanib increases expression ISO IGFBP1 (Homo sapiens) 6480464 vandetanib results in increased expression of IGFBP1 mRNA CTD PMID:16052530 vemurafenib multiple interactions ISO IGFBP1 (Homo sapiens) 6480464 [(+)-JQ1 compound co-treated with vemurafenib] results in increased expression of IGFBP1 protein CTD PMID:27169980 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of IGFBP1 mRNA and Zinc deficiency results in decreased expression of IGFBP1 protein CTD PMID:12672911 and PMID:20404036 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of IGFBP1 mRNA and Zinc deficiency results in decreased expression of IGFBP1 protein CTD PMID:12672911 and PMID:20404036